Candidate biomarker selection for the discovery cohort
The procedure for the selection of candidate biomarkers was as follows. Somatic genomic driver alterations (mutations and copy number alterations) were included as candidate biomarkers at increasingly specific ‘levels’: (1) gene-level biomarkers, for example, ‘